hydrochlorothiazide and 8-epi-prostaglandin f2alpha

hydrochlorothiazide has been researched along with 8-epi-prostaglandin f2alpha in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Knap, N; Larczynski, W; Neuwelt, A; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L; Wozniak, M	1
Ashcheulova, T; Demydenko, G; Gerasimchuk, N; Kochubiei, O; Rezunenko, Y	1

Trials

1 trial(s) available for hydrochlorothiazide and 8-epi-prostaglandin f2alpha

Article	Year
Spironolactone attenuates oxidative stress in patients with chronic kidney disease. Hypertension (Dallas, Tex. : 1979), 2008, Volume: 52, Issue:5 Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Benzimidazoles; Benzoates; Chronic Disease; Cilazapril; Creatinine; Cross-Over Studies; Dinoprost; Diuretics; Female; Humans; Hydrochlorothiazide; Kidney Diseases; Male; Mineralocorticoid Receptor Antagonists; Oxidative Stress; Spironolactone; Telmisartan	2008

Article

Year

Spironolactone attenuates oxidative stress in patients with chronic kidney disease.

Hypertension (Dallas, Tex. : 1979), 2008, Volume: 52, Issue:5

Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Benzimidazoles; Benzoates; Chronic Disease; Cilazapril; Creatinine; Cross-Over Studies; Dinoprost; Diuretics; Female; Humans; Hydrochlorothiazide; Kidney Diseases; Male; Mineralocorticoid Receptor Antagonists; Oxidative Stress; Spironolactone; Telmisartan

2008

Other Studies

1 other study(ies) available for hydrochlorothiazide and 8-epi-prostaglandin f2alpha

Article	Year
PATHOGENETIC ADVANCES OF FOSINOPRIL SODIUM WITH HYDROCHLOROTHIAZIDE IN OBESE HYPERTENSIVE PATIENTS. Georgian medical news, 2017, Issue:271 Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Case-Control Studies; Dinoprost; Diuretics; Drug Therapy, Combination; Endothelium, Vascular; Essential Hypertension; Female; Fosinopril; Humans; Hydrochlorothiazide; Male; Middle Aged; Nitric Oxide Synthase Type II; Obesity; Overweight; Receptors, Tumor Necrosis Factor, Type I; Tumor Necrosis Factor-alpha	2017

Article

Year

PATHOGENETIC ADVANCES OF FOSINOPRIL SODIUM WITH HYDROCHLOROTHIAZIDE IN OBESE HYPERTENSIVE PATIENTS.

Georgian medical news, 2017, Issue:271

Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Case-Control Studies; Dinoprost; Diuretics; Drug Therapy, Combination; Endothelium, Vascular; Essential Hypertension; Female; Fosinopril; Humans; Hydrochlorothiazide; Male; Middle Aged; Nitric Oxide Synthase Type II; Obesity; Overweight; Receptors, Tumor Necrosis Factor, Type I; Tumor Necrosis Factor-alpha

2017